Phase
Condition
Emphysema
Treatment
Placebo
dual anti-platelet therapy
Clinical Study ID
Ages 50-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria - COPD Cases:
COPD (FEV1/FVC < 0.7, FVC >= LLN), GOLD Stage I/II/III (FEV1 >= 40%)
Current or former smoker of at least 10 pack years
Inclusion Criteria - Controls:
Normal lung function (FEV1/FVC >= 0.7, FEV1 and FVC >= LLN)
Current or former smoker of at least 10 pack years
Exclusion
Exclusion Criteria:
Platelet count < 150,000/dL or self-report of a bleeding disorder;
Regular use of aspirin, clopidogrel or another antiplatelet medication;
Allergy to aspirin, clopidogrel, albuterol or iodine/IV contrast;
BMI > 35;
History of intracranial hemorrhage, severe GI bleed or other life-threatening bleed;
Use of blood thinner (e.g. warfarin, lovenox or novel oral anti-coagulants);
Continuous use of supplemental oxygen at home;
Regular use of an NSAID;
Daily use of oral steroids, theophylline, roflumilast, or loop diuretics;
History of organ transplant or autoimmune disease on systemic therapy (rheumatoidarthritis, lupus);
Use of a biologic medication with regular injections;
Other current lung disease (interstitial lung disease, idiopathic pulmonaryfibrosis, asthma);
IV drug use within the last year;
History of lung surgery to remove part of the lung;
Known bullae or advanced destructive emphysema in more than 1/3 of the lungs;
Treatment for cancer (systemic therapy or surgical/radiation within the thorax) inthe last 12 months;
Known diagnosis of pulmonary hypertension;
Known systolic heart failure (RV or LV EF < 40%);
Acute or chronic renal insufficiency (estimated glomerular filtration rate [GFR] <60mL/min/1.73 m2 or self-report). GFR will be calculated using the CKD-EPI equation;
Current or planned pregnancy in the next year;
Regular marijuana smoking;
Exacerbation of respiratory symptoms within the previous 6 weeks, such as thatrequiring hospitalization, oral prednisone or antibiotics to control symptoms, orlonger and not yet returned to baseline; and
Chest, abdominal or eye surgery, or a heart attack or stroke, within the last 3months.
Study Design
Study Description
Connect with a study center
Brigham and Women's Hospital
Boston, Massachusetts 02115
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.